• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Regeneron joins Koneksa Parkinson's digital biomarker study

cafead

Administrator
Staff member
  • cafead   Sep 04, 2024 at 11:42: AM
via Regeneron is the second pharma group to sign up for access to data from a remote study run by health technology firm Koneksa that is exploring the use of digital biomarkers to track patients with Parkinson's disease.

article source
 

<